查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1670814

2025年全球粒子治療市場報告

Particle Therapy Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年粒子束治療市場將快速成長。到 2029 年，這一數字將成長至 21.9 億美元，複合年成長率為 12.4%。預測期內的成長可歸因於醫療保健支出的增加、新的非腫瘤學應用、老年人口的成長、醫療保健基礎設施的發展以及人工智慧和資料分析的整合。預測期內的關鍵趨勢包括粒子加速器技術、低分次技術、聯合治療的進步、患者舒適度的提高以及生物主導的治療通訊協定。

預計癌症發生率的上升將推動未來粒子束治療市場的成長。癌症是一類複雜多樣的疾病，其特徵是體內細胞異常生長和增生。粒子療法透過將帶正電的粒子（質子）加速到高速並將其聚焦在腫瘤上，從而提供精確的輻射，從而有效地治療癌症。例如，總部設在法國的政府間機構國際癌症研究機構（IARC）2024年4月報告稱，2022年全球將新增約2,000萬例癌症病例，約1,000萬人死亡。根據人口趨勢預測，到2050年，全球每年新增癌症病例可能達到3,500萬例，比2022年增加77%。因此，癌症發生率的上升是推動粒子治療市場成長的關鍵因素。

預計未來幾年老齡人口的增加將促進粒子治療市場的成長。老化是指社會中老年人口比例不斷增加的人口變化。粒子療法對老年人特別有益，因為它為癌症治療提供了一種精確、有針對性的方法，最大限度地減少了對周圍健康組織的損害，並降低了長期副作用的風險，從而改善了接受癌症治療的老年患者的生活品質。例如，總部位於肯亞的非營利人口研究所在2024年1月估計，美國65歲以上人口數將增加47%，從2022年的5,800萬人增加至2050年的8,200萬人。該年齡層人口在總人口中所佔比例預計也在同一時期從17%增至23%。因此，老化是粒子束治療市場的關鍵驅動力。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球粒子治療PESTEL分析（政治、社會、技術、環境、法律因素、促進因素、限制因素）
  • 最終用途產業分析
  • 全球粒子治療市場：成長率分析
  • 全球粒子治療市場表現：規模與成長，2019-2024
  • 全球粒子治療市場預測：規模與成長，2024-2029年，2034年
  • 全球粒子治療總目標市場（TAM）

第6章市場區隔

  • 全球粒子治療市場：依類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 質子治療
  • 重粒子線治療
  • 全球粒子治療市場：按系統、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 單室系統
  • 多房間系統
  • 全球粒子束治療市場：按癌症類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 兒童癌症
  • 攝護腺癌
  • 肺癌
  • 乳癌
  • 腦和脊髓癌
  • 其他癌症類型
  • 全球粒子治療市場：依最終使用者、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 學術研究中心
  • 全球粒子治療市場，按類型細分：質子治療，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 筆射束掃描質子治療
  • 被動散射質子治療
  • 調變強質子治療（IMPT）
  • 全球粒子治療市場，按類型細分：重離子治療，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 碳離子療法
  • 氦離子療法
  • 其他重離子

第7章 區域和國家分析

  • 全球粒子治療市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球粒子治療市場：依國家、表現及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 粒子束治療市場：競爭格局
  • 粒子治療市場：公司簡介
    • Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Mitsubishi Electric Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • GE Healthcare Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems Inc.
  • Elekta AB
  • Shinva Medical Instrument Co. Ltd.
  • Toshiba Medical Systems Corporation
  • Brainlab AG
  • Accuray Incorporated
  • IBA Worldwide
  • Mevion Medical Systems Inc.
  • Avante Health Solutions
  • Provision Healthcare LLC
  • ViewRay
  • Panacea Biotec Ltd.
  • PTW Freiburg GmbH.
  • ProNova Solutions LLC

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年粒子治療市場：提供新機會的國家
  • 2029年粒子治療市場：細分領域帶來新機會
  • 2029年粒子治療市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r25184

Particle therapy is an advanced cancer treatment that employs charged particles, such as protons or heavier ions, to administer radiation therapy directly to cancerous tumors. This method primarily targets energetic ionizing particles at the tumor location, aiming to improve treatment outcomes for patients with various types of tumors, particularly those that are difficult to treat using conventional radiation therapy.

Two primary types of therapies fall under the umbrella of particle therapy, proton therapy and heavy ion therapy. Proton therapy is a specialized form of radiation therapy employed in cancer treatment. It encompasses both single-room systems and multi-room systems, providing versatility in its application. Proton therapy is utilized for the treatment of various cancers, including but not limited to pediatric cancer, prostate cancer, lung cancer, breast cancer, and cancers affecting the brain and spinal cord. The primary end users of particle therapy are hospitals, academic institutions, and research centers. Particle therapy offers a targeted and precise approach to cancer treatment, minimizing damage to surrounding healthy tissues and enhancing the therapeutic effectiveness of radiation.

The particle therapy market research report is one of a series of new reports from The Business Research Company that provides particle therapy market statistics, including particle therapy industry global market size, regional shares, competitors with a particle therapy market share, detailed particle therapy market segments, market trends and opportunities, and any further data you may need to thrive in the particle therapy industry. This particle therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The particle therapy market size has grown rapidly in recent years. It will grow from $1.23 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to clinical research and studies, increased cancer incidence, government support and funding, industry collaboration, and improvements in treatment planning

The particle therapy market size is expected to see rapid growth in the next few years. It will grow to $2.19 billion in 2029 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to increasing healthcare expenditure, emerging applications beyond cancer, a rise in the geriatric population, healthcare infrastructure development, AI and data analytics integration. Major trends in the forecast period include advancements in particle accelerator technology, hypofractionation techniques, proton and carbon ion combination therapy, improved patient comfort, and biology-driven treatment protocols.

The increasing prevalence of cancer is anticipated to drive the growth of the particle therapy market in the future. Cancer is a complex and varied group of diseases marked by the abnormal growth and multiplication of cells in the body. Particle therapy effectively treats cancer through precise radiation delivery, utilizing positively charged particles (protons) that are accelerated to high speeds and focused on the tumor. For instance, in April 2024, the International Agency for Research on Cancer (IARC), a France-based intergovernmental agency, reported that nearly 20 million new cancer cases were recorded in 2022, resulting in almost 10 million deaths. Projections based on demographic trends indicate that the annual incidence of new cancer cases could reach 35 million by 2050, representing a 77% increase from the 2022 figures. Therefore, the rising prevalence of cancer is a key factor driving the growth of the particle therapy market.

The increasing aging population is projected to contribute to the growth of the particle therapy market in the coming years. An aging population refers to a demographic shift characterized by a growing proportion of elderly individuals within a society. Particle therapy is particularly beneficial for the geriatric population as it offers a precise and targeted approach to cancer treatment, minimizing damage to surrounding healthy tissues and reducing the risk of long-term side effects, thereby enhancing the quality of life for older patients receiving cancer therapy. For example, in January 2024, the Population Reference Bureau, a Kenya-based nonprofit organization, estimated that the number of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, marking a 47% increase. This age group's share of the total population is also expected to grow from 17% to 23% during the same period. Thus, the aging population is a significant driver of the particle therapy market.

Advanced particle therapy platforms are becoming a significant trend in the particle therapy market. Key players in this field are focusing on developing innovative particle therapy solutions to maintain their competitive edge. For example, in July 2023, RaySearch Laboratories, a Sweden-based medical technology firm, introduced RayStation 2023B. This comprehensive oncology treatment planning system incorporates several groundbreaking advancements in particle therapy, including support for discrete proton arcs and robust optimization based on linear energy transfer (LET). LET optimization aims to minimize potential side effects by reducing LET in at-risk organs while directing high LET particles to tumors for better tumor control. Additionally, discrete proton arc optimization allows for a wider range of beam angles, resulting in more conformal dose distributions and less exposure for sensitive organs. The software also offers easy conversion to standard pencil-beam scanning plans, automatic field-in-field planning for photon treatments, point-based optimization for brachytherapy, and improved data loading speeds.

Key companies in the particle therapy market are intensifying their efforts to develop innovative therapies, with a particular focus on proton therapy solutions, to gain a competitive advantage. Proton therapy technology, a sophisticated form of cancer treatment utilizing protons and positively charged particles, delivers precise and targeted radiation to cancer cells. For instance, in April 2023, P-Cure, an Israel-based high-med-tech company, obtained clearance from the United States Food and Drug Administration (USFDA) for its Adaptive Proton Therapy Solution, allowing sales in the USA. This affordable proton therapy technology is designed for targeted cancer treatment with significantly reduced treatment-related side effects. P-Cure's innovative upright solution, the world's first FDA-approved methodology for patient positioning, enables seated treatment, enhancing both patient comfort and clinical outcomes.

In May 2022, Brainlab AG, a Germany-based medical technology company, acquired a majority stake in medPhoton GmbH for an undisclosed amount. This strategic acquisition aims to expand Brainlab's intraoperative imaging portfolio, drive business growth, bolster product development, and accelerate innovation in the critical field of medical technology. medPhoton GmbH, an Austria-based medical equipment manufacturing company, specializes in providing particle therapy devices and services.

Major companies operating in the particle therapy market include Hitachi Ltd., Mitsubishi Electric Corporation, Siemens Healthineers AG, Koninklijke Philips N.V, GE Healthcare, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., Elekta AB, Shinva Medical Instrument Co. Ltd., Toshiba Medical Systems Corporation, Brainlab AG, Accuray Incorporated, IBA Worldwide, Mevion Medical Systems Inc., Avante Health Solutions, Provision Healthcare LLC, ViewRay, Panacea Biotec Ltd., PTW Freiburg GmbH., ProNova Solutions LLC, Optivus Proton Therapy Inc., Xstrahl Inc., Protom International Inc., Danfysik AS, SAH Global LLC, Advanced Oncotherapy plc, Particle Therapy Co-Operative Group, Best Particle Therapy Inc.

North America was the largest region in the particle therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the particle therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The particle therapy market includes of revenues earned by entities by providing particle therapy services such as treatment planning, particle beam delivery, imaging and simulation, treatment sessions, patient monitoring, and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Particle Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on particle therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for particle therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The particle therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Proton Therapy; Heavy Ion Therapy
  • 2) By System: Single-Room Systems; Multi-Room Systems
  • 3) By Cancer Type: Pediatric Cancer; Prostate Cancer; Lung Cancer; Breast Cancer; Brain And Spinal Cord Cancer; Other Cancer Types
  • 4) By End-User: Hospital; Academic And Research Centers
  • Subsegments:
  • 1) By Proton Therapy: Pencil Beam Scanning Proton Therapy; Passive Scattering Proton Therapy; Intensity-Modulated Proton Therapy (IMPT)
  • 2) By Heavy Ion Therapy: Carbon Ion Therapy; Helium Ion Therapy; Other Heavy Ions
  • Companies Mentioned: Hitachi Ltd.; Mitsubishi Electric Corporation; Siemens Healthineers AG; Koninklijke Philips N.V; GE Healthcare
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Particle Therapy Market Characteristics

3. Particle Therapy Market Trends And Strategies

4. Particle Therapy Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Particle Therapy Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Particle Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Particle Therapy Market Growth Rate Analysis
  • 5.4. Global Particle Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Particle Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Particle Therapy Total Addressable Market (TAM)

6. Particle Therapy Market Segmentation

  • 6.1. Global Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Proton Therapy
  • Heavy Ion Therapy
  • 6.2. Global Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Room Systems
  • Multi-Room Systems
  • 6.3. Global Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pediatric Cancer
  • Prostate Cancer
  • Lung Cancer
  • Breast Cancer
  • Brain And Spinal Cord Cancer
  • Other Cancer Types
  • 6.4. Global Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital
  • Academic And Research Centers
  • 6.5. Global Particle Therapy Market, Sub-Segmentation Of Proton Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pencil Beam Scanning Proton Therapy
  • Passive Scattering Proton Therapy
  • Intensity-Modulated Proton Therapy (IMPT)
  • 6.6. Global Particle Therapy Market, Sub-Segmentation Of Heavy Ion Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Carbon Ion Therapy
  • Helium Ion Therapy
  • Other Heavy Ions

7. Particle Therapy Market Regional And Country Analysis

  • 7.1. Global Particle Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Particle Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Particle Therapy Market

  • 8.1. Asia-Pacific Particle Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Particle Therapy Market

  • 9.1. China Particle Therapy Market Overview
  • 9.2. China Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Particle Therapy Market

  • 10.1. India Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Particle Therapy Market

  • 11.1. Japan Particle Therapy Market Overview
  • 11.2. Japan Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Particle Therapy Market

  • 12.1. Australia Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Particle Therapy Market

  • 13.1. Indonesia Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Particle Therapy Market

  • 14.1. South Korea Particle Therapy Market Overview
  • 14.2. South Korea Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Particle Therapy Market

  • 15.1. Western Europe Particle Therapy Market Overview
  • 15.2. Western Europe Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Particle Therapy Market

  • 16.1. UK Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Particle Therapy Market

  • 17.1. Germany Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Particle Therapy Market

  • 18.1. France Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Particle Therapy Market

  • 19.1. Italy Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Particle Therapy Market

  • 20.1. Spain Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Particle Therapy Market

  • 21.1. Eastern Europe Particle Therapy Market Overview
  • 21.2. Eastern Europe Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Particle Therapy Market

  • 22.1. Russia Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Particle Therapy Market

  • 23.1. North America Particle Therapy Market Overview
  • 23.2. North America Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Particle Therapy Market

  • 24.1. USA Particle Therapy Market Overview
  • 24.2. USA Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Particle Therapy Market

  • 25.1. Canada Particle Therapy Market Overview
  • 25.2. Canada Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Particle Therapy Market

  • 26.1. South America Particle Therapy Market Overview
  • 26.2. South America Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Particle Therapy Market

  • 27.1. Brazil Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Particle Therapy Market

  • 28.1. Middle East Particle Therapy Market Overview
  • 28.2. Middle East Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Particle Therapy Market

  • 29.1. Africa Particle Therapy Market Overview
  • 29.2. Africa Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Particle Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Particle Therapy Market Competitive Landscape
  • 30.2. Particle Therapy Market Company Profiles
    • 30.2.1. Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Mitsubishi Electric Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Koninklijke Philips N.V Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GE Healthcare Overview, Products and Services, Strategy and Financial Analysis

31. Particle Therapy Market Other Major And Innovative Companies

  • 31.1. Sumitomo Heavy Industries Ltd.
  • 31.2. Varian Medical Systems Inc.
  • 31.3. Elekta AB
  • 31.4. Shinva Medical Instrument Co. Ltd.
  • 31.5. Toshiba Medical Systems Corporation
  • 31.6. Brainlab AG
  • 31.7. Accuray Incorporated
  • 31.8. IBA Worldwide
  • 31.9. Mevion Medical Systems Inc.
  • 31.10. Avante Health Solutions
  • 31.11. Provision Healthcare LLC
  • 31.12. ViewRay
  • 31.13. Panacea Biotec Ltd.
  • 31.14. PTW Freiburg GmbH.
  • 31.15. ProNova Solutions LLC

32. Global Particle Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Particle Therapy Market

34. Recent Developments In The Particle Therapy Market

35. Particle Therapy Market High Potential Countries, Segments and Strategies

  • 35.1 Particle Therapy Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Particle Therapy Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Particle Therapy Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer